Cell proliferation assays

CF Christian Freise
HL Hyunho Lee
CC Christopher Chronowski
DC Doug Chan
JC Jessica Cziomer
MR Martin Rühl
TD Tarkan Dagdelen
ML Maik Lösekann
UE Ulrike Erben
AC Andre Catic
WT Werner Tegge
DS Detlef Schuppan
RS Rajan Somasundaram
ES Ergun Sahin
request Request a Protocol
ask Ask a question
Favorite

5x103CFSC in 100 μl 10% FBS were seeded into a 96-well flat-bottom tissue culture plate (Nunc, Roskilde, Denmark). After 24 hours, medium was completely removed, and cells were rinsed with 200 μl phosphate-buffered saline and 100 μl standard medium containing only 0.25% FBS were added. Cells were cultured for additional 24 h prior to treatment. Synchronized microcultures in 96-well plates were treated for 2 hours in reduction medium. When appropriate, the reduction medium was supplemented with 40 mg/l of α1(VI), α2(VI) or α3(VI). Then, 30 mg/l CVI or CI as control were added and cells were incubated for 24 h after which [3H]-thymidine was added for additional 24 h. To assess effects of α3(VI)-derived 30-mer peptides on CVI-induced proliferation of CFSC, the reduction medium was supplemented with a 100-fold molar excess of the respective 30-mer peptides compared to CVI. [3H]-thymidine incorporation was measured as described before [20]. Cells treated with 150 mmol/l HAc or grown in 10% FBS served as negative and positive controls, respectively. During the last 4 hours of treatment, all cultures received 18.5 kBq [3H]-thymidine (Amersham, Freiburg, Germany). Cells were fixed with 10% trichloroacetic acid and lysed by 200 mmol/l NaOH. After neutralization with 800 mmol/l HCl, lysates were collected to a glassfibre mat and the de-novo DNA synthesis was assessed by liquid scintillation (LKB Wallac, Bromma, Sweden) and the radioactive decay was counted (for) a minute (cpm).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A